Results 281 to 290 of about 804,384 (336)
Some of the next articles are maybe not open access.

Combined Modality Therapy of Esophageal Cancer

Journal of the National Comprehensive Cancer Network, 2008
Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of ...
Rosalyn A, Juergens, Arlene, Forastiere
openaire   +2 more sources

Combined modality therapy of malignant melanoma

World Journal of Surgery, 1979
AbstractThe major modalities of therapy, namely, surgery, radiotherapy, chemotherapy, and immunotherapy, are each of value in selected cases of malignant melanoma. However, because none of these therapies, alone, is capable of curing or controlling some subgroups of melanoma patients, combined modality therapy needs to be used more extensively. Surgery
E M, Hersh, J U, Gutterman, C M, McBride
openaire   +2 more sources

Combined modality therapy for esophageal cancer

Seminars in Oncology, 2003
Treatment approaches for esophageal cancer include primary treatment (surgical or nonsurgical) or adjuvant treatment (preoperative or postoperative). Primary treatments include surgery alone, radiation therapy alone, and radiation therapy plus chemotherapy (combined modality therapy).
openaire   +2 more sources

Combination modality cancer therapy

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
Coordination compounds for use in therapy, the compounds having the general empirical formula [Rhm Xx Yy ]a in which m is the oxidation state of Rh, X is at least one anionic ligand, Y is at least one neutral ligand, with the proviso that at least one of X and Y is a nitrogen donor ligand, x is an integer from 1 to 6, y is an integer from 1 to 5 or may
Donald H Picker, Paul C Hydes
openaire   +1 more source

Combined modality therapy for intracranial tumors

Cancer, 1975
Three types of tumor (supratentorial astrocytoma, medulloblastoma, and craniopharyngioma), each requiring a fundamentally different therapeutic approach, will be used to illustrate the principles and practice of combined treatment in this field. The role of radiotherapy and ways of enhancing the effect of irradiation will be considered.
openaire   +2 more sources

Thyroid lymphoma. The case for combined modality therapy

Cancer, 1994
Radiation therapy with or without surgery is generally considered standard treatment for lymphoma of the thyroid. Because of the small number of cases, the role of chemotherapy or combined modality treatment is difficult to determine.The published literature was analyzed, supplemented by a series from Yale, for the incidence of local and distant ...
R, Doria, J F, Jekel, D L, Cooper
openaire   +2 more sources

Combined modality therapy of acute lymphocytic leukemia

Cancer, 1975
The progressive improvement in the prognosis of acute lymphocytic leukemia has been a result of two major developments: 1) the more efficient use of chemotherapeutic agents, particularly the use of combinations of agents and the discovery that agents effective at one stage of disease may be inappropriate at another stage, and 2) the prevention with ...
J V, Simone   +4 more
openaire   +2 more sources

Chemotherapy and Combined-Modality Therapy for Esophageal Cancer

Chest, 1995
Treatment of esophageal carcinoma with radiation alone or surgery alone has yielded unsatisfactory cure rates and has not had a major impact on survival. The failure to cure or prolong survival of patients with esophageal cancer is because of our inability to eradicate residual disease at the primary site and to early systemic dissemination of disease.
D P, Kelsen, D H, Ilson
openaire   +2 more sources

Taxanes in combined modality therapy for solid tumors

Critical Reviews in Oncology/Hematology, 2001
The taxanes, paclitaxel and docetaxel, are novel antimitotic agents that are under extensive investigation in clinical trials. Both taxanes have demonstrated significant activity against many solid tumors as single agents and in combination with other chemotherapeutic agents.
openaire   +3 more sources

Combined modality therapy for rectal and colon cancer

Seminars in Oncology, 2003
Combined modality therapy (CMT) with radiation therapy and chemotherapy plays an important role in the management of rectal cancer. Postoperatively, pelvic irradiation and 5-fluorouracil-based chemotherapy have been used to improve local control and survival for high-risk patients after local excision, as well as for patients undergoing ...
Ashish K, Chawla   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy